StockData
Revolution Medicines, Inc. logo

Revolution Medicines, Inc. (RVMD) stock

RVMDNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31Also trades as RVMDW
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 3/30
$162.69−4.18 (-2.50%)

Close on Nov 17, 2026Market cap $34.87BP/E –Yield –

Revolution Medicines EV/EBITDA

EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.

No ev/ebitda figures for Revolution Medicines

Revolution Medicines has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Revolution Medicines figures

See a number that looks wrong?